Vitiligo trials in Germany

3 of 5 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

  Where

  Bad Bentheim, Bielefeld, Frankfurt Am Main, Hamburg, Hanover, Luebeck, Muenster, Munich, Tuebingen

  Age

  18 years to 99 years

  People

  210 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07431177 · EU 2025-522301-37-00
• Phase 3Taking people
  Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  Where

  Aachen, Bad Bentheim, Berlin, Bochum, Buxtehude, Darmstadt, Dortmund, Dresden, Duesseldorf, Erlangen, Frankfurt Am Main, Goettingen, Hamburg, Hannover, Heidelberg, Kiel, Leipzig, Luebeck, Magdeburg, Mainz, Merzig, Muenster, Munich, Oldenburg, Tuebingen, Witten

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Incyte Corporation

  See details and how to joinNCT06855498 · EU 2024-520107-12-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

  Where

  Berlin, Erlangen, Hamburg, Kiel, Leipzig, Mainz, Muenster, Munich

  Age

  6 years to 11 years

  People

  250 worldwide

  Run by

  Incyte Corporation

  See details and how to joinNCT06804811 · EU 2024-513171-41-00